Nuvectis PharmaNVCT
13F holders, Q1 2025 (March 31)At the end of Q1 2025, 33 institutions reported holding Nuvectis Pharma Inc. (NVCT) in their 13F filings, up 2 from Q4 2024. 10 opened new positions and 7 sold out. The largest holders were Vanguard Group Inc. ($4.6M), Baldwin Wealth Partners LLC ($3.5M) and Iridian Asset Management LLC ($2.5M). 2 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Nuvectis Pharma Inc.
- CUSIP
- 67080T108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 10 | $4.5M |
| Exits | 7 | $475K |
All 13F filers, Q4 2024 → Q1 2025: 907,869 shares bought and 181,502 shares sold, net +726,367 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 33 holders
| Vanguard Group Inc. | 0.00% | Add +43.7% | 467,419 | $4.6M |
| Baldwin Wealth Partners LLC | 0.25% | Add +0.7% | 358,461 | $3.5M |
| Iridian Asset Management LLC | 0.78% | New | 253,972 | $2.5M |
| Geode Capital Management, LLC | 0.00% | Add +70.8% | 135,333 | $1.3M |
| Millennium Management | 0.00% | Add +307.8% | 121,101 | $1.2M |
| UBS Group AG | 0.00% | Add +4078.3% | 111,520 | $1.1M |
| BlackRock, Inc. | 0.00% | Add +9.8% | 68,484 | $669K |
| Forbes J M & Co. LLP | 0.06% | No change | 59,000 | $576K |
| Goldman Sachs Group Inc. | 0.00% | New | 45,608 | $446K |
| Austin Wealth Management, LLC | 0.09% | New | 40,250 | $441K |
| Jane Street Group, LLC | 0.00% | New | 42,299 | $413K |
| Oppenheimer & Co. Inc. | 0.01% | Add +64.0% | 41,000 | $401K |
| Marshall Wace, LLP | 0.00% | Reduce -68.8% | 38,874 | $380K |
| Northern Trust Corp. | 0.00% | Add +47.9% | 38,058 | $372K |
| Gsa Capital Partners LLP | 0.03% | No change | 34,751 | $340K |
| OMERS ADMINISTRATION Corp | 0.00% | New | 32,882 | $321K |
| State Street Corp. | 0.00% | Add +26.1% | 27,750 | $271K |
| Two Sigma Investments, LP | 0.00% | Add +8.2% | 20,093 | $196K |
| Edmond DE Rothschild Holding S.A. | 0.00% | No change | 15,170 | $148K |
| Baxter Bros Inc. | 0.02% | No change | 15,000 | $147K |
| Nations Financial Group Inc, /Ia/ | 0.01% | No change | 13,500 | $132K |
| Balyasny Asset Management L.P. | 0.00% | New | 13,483 | $132K |
| Squarepoint Ops LLC | 0.00% | Reduce -42.3% | 11,012 | $108K |
| Blue Zone Wealth Advisors, LLC | 0.03% | New | 10,424 | $102K |
| Citadel Advisors | 0.00% | New | 10,344 | $101K |
| Jain Global LLC | 0.00% | New | 10,154 | $99K |
| Morgan Stanley | 0.00% | Add +200.9% | 6,977 | $68K |
| Bank of America Corp. | 0.00% | Add +2.5% | 1,656 | $16K |
| Barclays PLC | 0.00% | Add +1.3% | 1,159 | $11K |
| Citigroup Inc. | 0.00% | New | 1,025 | $10K |
| JPMorgan Chase & Co. | 0.00% | No change | 179 | $2K |
| BNP Paribas Financial Markets | 0.00% | Reduce -11.3% | 102 | $997 |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 100 | $977 |
"% of holder's portfolio" is NVCT's weight in each manager's 13F, not the share of Nuvectis Pharma Inc. the manager owns.